Don Delves

Oct 25, 2024 | corpgov.law.harvard.edu | John M. Bremen |Kenneth Kuk |Don Delves

Board of Directors, Corporate governance, Human capital, ManagementMore from: Don Delves, John M. Bremen, Kenneth Kuk, Willis Towers WatsonJohn M. Bremen is a Managing Director and Chief Innovation & Acceleration Officer, Kenneth Kuk is a Senior Director, and Don Delves is a Managing Director at Willis Towers Watson. This post is based on their Willis Towers Watson memorandum. Boards of directors are increasingly prioritizing their role in the oversight and governance of human capital.

Jul 23, 2024 | directorsandboards.com | Don Delves

In many ways, the global economy is at a tipping point. Developments in AI and quantum computing promise infinitely higher productivity and insight while also creating disruption. Talent shortages for key skills likely will last for decades. Businesses seek more sustainable ways to compete in a low-carbon economy. Geopolitical challenges proliferate. Human potential has become more important than ever as a competitive advantage.

Jun 6, 2024 | directorsandboards.com | Don Delves

While total shareholder return (TSR) remains the single most common performance measure used in executive incentive plans — and long-term incentive plans in particular — its use has evolved significantly over time and has become more nuanced and sophisticated. However, to better understand what is happening now, and what may happen next, it may be useful to review the evolution of performance measures in incentive plans over time.

Nov 8, 2023 | directorsandboards.com | Don Delves |John M. Bremen

Never before has board oversight of human capital management — and employee well-being specifically — been more important or relevant to corporate governance and performance. In today's complex and constantly changing environment, effective board members increasingly care whether company employees have an obesity problem, diabetes, high blood pressure, unusual levels of heart disease or mental health issues.